Tatyana Belinsky
Psychiatry · Camden, NJNPI 1902990229
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 305 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,530 and has fallen 75.5% since, to $376 in 2022. Among psychiatry clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 305 payments — averaging $13.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$753
- Sunovion Pharmaceuticals Inc.$731
- Otsuka America Pharmaceutical, Inc.$530
- Alkermes, Inc.$492
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$370
- Johnson & Johnson$286
- plus $935 from 10 others
What the payments were for
- Food & beverage$4,02098%
- Education$772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 61 | $753 |
| Sunovion Pharmaceuticals Inc. | 58 | $731 |
| Otsuka America Pharmaceutical, Inc. | 37 | $530 |
| Alkermes, Inc. | 35 | $492 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $370 |
| Johnson & Johnson | 23 | $286 |
| Lundbeck LLC | 15 | $201 |
| Teva Pharmaceuticals USA, Inc. | 13 | $173 |
| Neurocrine Biosciences, Inc. | 10 | $134 |
| Vanda Pharmaceuticals Inc. | 9 | $129 |
| Noven Therapeutics, LLC | 7 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $69 |
| Indivior Inc. | 3 | $52 |
| Validus Pharmaceuticals LLC | 3 | $40 |
| Almatica Pharma LLC | 2 | $25 |
| Shire North American Group Inc | 1 | $15 |
How this compares
$4,096 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Camden
- Anthony RostainCamden$110K
- Venitius NunezCamden$16K
- Marc CantillonLivingston$522K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
- Leon RosenbergCherry Hill$257K
- Lloyd AlceraMarlton$187K
- Gary SmallHackensack$170K
- Shankar SrinivasanParsippany$155K
- Matthew PiteraToms River$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.